VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mkilloran who wrote (18381)	1/29/1999 9:35:00 PM
From: VLAD	Read Replies (1) of 23519

martin, I have to disagree with your reasons for the European delays. What does England's NHS have to do with policy in France and Germany? They have already decided NOT to pay for Viagra. I assume that MUSE will be covered by their national health plans because there really is no abuse potential like Viagra. Every elderly male has some form of erectile dysfunction in the sense that their ability to achieve and maintain an erection is not as good as it was when they were younger. Deterioration of sexual function is no different than what happens to other bodily functions (eg hearing, vision, joint mobility) as we age. For this reason, any elderly man can go to his doctor claiming to have ED and technically he is not lying. But what he is really suffering from is aging and not ED. It would be interesting to know exactly why some of these important European countries have not granted MUSE individual licensing within the standard 30 days. It it because Vivus was depending on Astra to do the required paper work and Astra has been slow because of its Zeneca merger? Perhaps it is because Vivus itself was slow in filing the required paper work? Now THAT would explain everything!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next